Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 in Essential Hypertension
NCT01193101Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2010
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of sacubitril + valsartan in essential hypertension, sponsored by Novartis. Started Aug 2010; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01193101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193101.